These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12486788)

  • 1. Fungal infection in liver transplantation.
    Fung JJ
    Transpl Infect Dis; 2002; 4 Suppl 3():18-23. PubMed ID: 12486788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum of fungal infections after orthotopic liver transplantation.
    Castaldo P; Stratta RJ; Wood RP; Markin RS; Patil KD; Shaefer MS; Langnas AN; Reed EC; Li SJ; Pillen TJ
    Arch Surg; 1991 Feb; 126(2):149-56. PubMed ID: 1992992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of fungal infection and increased mortality in liver transplant recipients.
    Rabkin JM; Oroloff SL; Corless CL; Benner KG; Flora KD; Rosen HR; Olyaei AJ
    Am J Surg; 2000 May; 179(5):426-30. PubMed ID: 10930495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infection in lung transplantation.
    Kubak BM
    Transpl Infect Dis; 2002; 4 Suppl 3():24-31. PubMed ID: 12486789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.
    Singh N; Paterson DL; Gayowski T; Wagener MM; Marino IR
    Transplantation; 2001 Apr; 71(7):910-3. PubMed ID: 11349726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview: fungal infections in the transplant patient.
    Fishman JA
    Transpl Infect Dis; 2002; 4 Suppl 3():3-11. PubMed ID: 12486786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal infections after liver transplantation: incidence and outcome.
    Sganga G; Bianco G; Frongillo F; Lirosi MC; Nure E; Agnes S
    Transplant Proc; 2014 Sep; 46(7):2314-8. PubMed ID: 25242777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal infections in solid-organ transplantation.
    Paya CV
    Clin Infect Dis; 1993 May; 16(5):677-88. PubMed ID: 8507760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for fungal infections in leukemia.
    Segal RE; Minamoto GY
    Curr Oncol Rep; 2001 May; 3(3):201-8. PubMed ID: 11296129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
    Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
    Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent.
    Singh N; Gayowski T; Wagener MM; Doyle H; Marino IR
    Clin Infect Dis; 1997 Feb; 24(2):179-84. PubMed ID: 9114144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
    Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
    Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
    O'Donnell MR; Schmidt GM; Tegtmeier BR; Faucett C; Fahey JL; Ito J; Nademanee A; Niland J; Parker P; Smith EP
    J Clin Oncol; 1994 Apr; 12(4):827-34. PubMed ID: 8151325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of fungal infection after liver transplantation.
    Shi XJ; Lü SC; He L; Lu F; Liang YR; Luo Y; Ji WB; Zhao ZM
    Chin Med J (Engl); 2011 Apr; 124(7):1015-7. PubMed ID: 21542960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in invasive fungal disease.
    Groll AH; Lumb J
    Future Microbiol; 2012 Feb; 7(2):179-84. PubMed ID: 22324986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.